Interestingly, LYPD3 expression is markedly attenuated in the non-invasive stage of cutaneous malignant lesions (carcinoma in situ), but re-activated upon transformation to malignant invasive squamous cell carcinoma, especially in the invasive front region. The gene discussed is LYPD3; the disease is in situ carcinoma.